We performed immunostaining of EGFR, ASAP1, ERBB2, ERBB4 and β-catenin in HBL tumor tissue from an expanded cohort of children treated with liver transplantation (n = 19) or with surgical resection (n = 40) and biopsy (n = 1). This evidence concerns the gene ERBB2 and hepatoblastoma.